Valuation
26% of the score, 30% here after data gaps
60median 13
Aurinia Pharmaceuticals Inc. is valued at 15x its operating profit, including debt: an ordinary multiple.
25x
20x
15x
10x
6x
15x
Full points at 6x or less, none from 25xfull points
AUPHAurinia Pharmaceuticals Inc.
$16.52+34% 1Y
$16.52
$11.0552 weeks$18.62
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 35 out of 100, Below average
Below average. Aurinia Pharmaceuticals Inc. scores higher than 30% of the 1,794 companies Ryufin scores.
Carried by the balance sheet, held back by return on capital and return on new capital.
Healthcare median 27 · all companies 50
Return on capital
18% of the score, 20% here after data gaps
0median 34
Over 6 years the business earned -21% a year after tax on the capital it uses.
2%
8%
15%
25%
-21%
None at 2% or less, full points from 25%full points
6 years agolatest 22%
Return on new capital
16% of the score, 18% here after data gaps
0median 49
No operating profit over the period, so nothing was earned to reinvest.
Capital allocation
14% of the score, 16% here after data gaps
54median 64
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countUp 3.2% a year over 5 years: new shares
235%
-3%
3.2%
0 pointsfull points
Assets against salesAssets grew 10% a year, sales 41%
10012%
-2%
-31%
0 pointsfull points
Cycle position
Taken out: its 12% is shared by the others
n/ano data
Margins have been too thin to measure a cycle against.
Balance sheet
8% of the score, 9% here after data gaps
100median 50
What the debt weighs against the profit that has to carry it.
Interest coverOperating profit covers interest 37x
1001.5x
12x
36.7x
0 pointsfull points
Earnings quality
6% of the score, 7% here after data gaps
0median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
Cash against profitOperating cash flow was 0.68x profit over 3 years
00.7x
1x
1.3x
0.7x
0 pointsfull points
AccrualsProfit ran ahead of cash by 23.3% of assets
08%
0%
-8%
23%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For AUPH, cycle position could not be measured from the filings, so it is taken out and the remaining weights scale up.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.